FactSet and MetLife face headwinds while Colgate-Palmolive shows competitive advantages

Industry
โดย Yahoo Finance·Read original
Summary · why it matters

Among S&P 500 stocks, FactSet and MetLife are facing challenges while Colgate-Palmolive demonstrates competitive strengths. FactSet's annual sales growth of 5.8% and earnings per share growth of 5.9% over the last two years have underperformed the financial sector, and its stock trades at 12.1 times forward price-to-earnings. MetLife's net premiums earned grew just 2.7% annually over five years, earnings per share rose only 10.8% annually over two years, and book value per share declined 10.8% annually over five years amid credit quality concerns, with shares at 1.9 times forward price-to-book. In contrast, Colgate-Palmolive benefits from a $20.8 billion revenue base providing retail leverage, a 60.4% gross margin from premium pricing, and a 17.8% free cash flow margin enabling consistent reinvestment or capital returns, trading at 24.1 times forward price-to-earnings.

Impact on stocks 3

Consumer Staples▲ · 1 stocks
Colgate-Palmolive Company
CL
▲ PositiveCapitalrelevance

Article highlights Colgate-Palmolive's strong gross margin, free cash flow margin, and premium pricing as competitive advantages, supporting its valuation.

Cloud & Digital Infrastructure▼ · 1 stocks
FactSet Research Systems Inc
FDS
▼ NegativeCapitalrelevance

Article notes FactSet's underperformance in sales and earnings growth relative to the financial sector, and its stock trades at a low forward P/E.

Aging Population▼ · 1 stocks
MetLife Inc
MET
▼ NegativeCapitalrelevance

Article cites MetLife's weak premium growth, declining book value, and credit quality concerns, with shares at low price-to-book.

© 2026 MarketDXNews